CAS 1227666-13-8
:NATEGLINIDE-PHENYL-D5
Description:
Nateglinide-phenyl-D5, identified by its CAS number 1227666-13-8, is a deuterated derivative of nateglinide, a medication primarily used in the management of type 2 diabetes. As a rapid-acting insulin secretagogue, it stimulates insulin release from the pancreas in response to meals, thereby helping to control postprandial blood glucose levels. The deuterated form, indicated by the "D5" in its name, suggests that it contains five deuterium atoms, which are isotopes of hydrogen. This modification can enhance the stability and metabolic tracking of the compound in pharmacokinetic studies. Nateglinide-phenyl-D5 retains the core structure of nateglinide, which includes a phenyl group and a carboxylic acid moiety, contributing to its biological activity. The presence of deuterium may also influence its pharmacological properties, such as absorption and elimination rates. Overall, this compound serves as a valuable tool in research, particularly in studies focused on drug metabolism and the pharmacodynamics of diabetes medications.
Formula:C19H22D5NO3
Synonyms:- NATEGLINIDE-PHENYL-D5
- NATEGLINIDE-D5
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Nateglinide-d5
CAS:Formula:C19H22D5NO3Color and Shape:White To Off-White SolidMolecular weight:322.46Nateglinide D5
CAS:Nateglinide D5 is a deuterium labeled Nateglinide.Formula:C19H27NO3Purity:98%Color and Shape:SolidMolecular weight:322.45Nateglinide-d5
CAS:Controlled Product<p>Applications A labelled version of Nateglinide, an amino-acid derivative that stimulates insulin secretion which is used as an antidiabetic.<br>References Shinkai, H., et al.: J. Med. Chem., 32, 1436 (1989), Sato, Y., et al.: Diabetes Res. Clin. Pract., 12, 53 (1991), Vicent, D., et al.: J. Clin. Invest., 111, 1373 (2003), Ceriello, A., et al.: Diabet. Med., 21, 171 (2004),<br></p>Formula:C192H5H22NO3Color and Shape:NeatMolecular weight:322.45
